MBMerle M. Böhmer

Merle M. Böhmer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Merle M. Böhmer has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HPV vaccination coverage among women aged 18–20 years in Germany three years after recommendation of HPV vaccination for adolescent girls

    by Yvonne Deleré, Merle M Böhmer, Dietmar Walter, Ole Wichmann

    Objective: Routine immunization of adolescent girls aged 12–17 y against human papillomavirus (HPV) was recommended in Germany in March 2007. We aimed to assess HPV-vaccine uptake and knowledge about post-vaccination cervical cancer screening and condom use in women aged 18–20 years, three years after adoption of HPV-vaccination into the routine vaccination schedule. Results: Overall 2,001 females participated in our study. Of these, 49% reported receipt of a complete three-dose course of HPV-vaccines; 11% received 1 or 2 doses. Living in East Germany, high educational status, and interest in health-related issues were independently associated with HPV-vaccination. Misconceptions among survey-participants were rare: Only 8% believed that HPV-vaccination would obviate the need for cervical screening and 1% that condom use would be dispensible after vaccination. Methods: In 2010, a nationwide cross-sectional telephone-survey was performed among randomly-selected women aged 18–20 years living in Germany. Telephone interviews were conducted by a large professional market research institute as part of a daily omnibus survey. Conclusion: HPV-vaccination coverage is low in Germany. The results indicate that there is an urgent need for the implementation of a coordinated adolescent vaccination program to facilitate access to vaccination, including balanced information tailored to this age group. Otherwise, the HPV-vaccination effort will fall short of reaching its maximum public health benefit.


  • Pertussis-Impfquoten bei Erwachsenen in Deutschland

    by M. M. Böhmer, W. Hellenbrand, D. Matysiak-Klose, U. Heininger, S. Müters, O. Wichmann

    Hintergrund: Während in Deutschland seit 2001 eine Pertussis-Impfempfehlung für Risikogruppen besteht, wird erst seit 2009 von der Ständigen Impfkommission allen Erwachsenen die einmalige Pertussis-Impfung bei der nächsten fälligen Tetanus-Diphtherie-Auffrischimpfung empfohlen. Ziele dieser Studie waren: 1) Erhebung von Pertussis-Impfquoten bei Erwachsenen, 2) Abschätzung der Verwendungshäufigkeit tetanushaltiger Kombinationsimpfstoffe in Krankenhäusern. Methoden: Für 1) wurden Daten zweier bevölkerungsrepräsentativer Telefonsurveys unter Erwachsenen 2009/2010 analysiert (GEDA09: n = 21 262; GEDA10: n = 22 050). Einflussfaktoren des Pertussis-Impfstatus in Risikogruppen wurden mit logistischen Regressionsverfahren bestimmt. Für 2) wurde eine Befragung von 133 Krankenhausapotheken (betreuen 454 Krankenhäuser) für das Jahr 2007 durchgeführt. Ergebnisse: In GEDA10 hatten 5,9 % (95 %-Konfidenzintervall [KI] 5,5–6,3 %) der Befragten einen ausreichenden Pertussis-Impfschutz (Impfung in letzten 10 Jahren). Erwachsene, die einer Risikogruppe angehörten, hatten eine Impfquote von 10,7 % (95 %-KI 9,8–11,7 %). Mit höheren Pertussis-Impfquoten in Risikogruppen signifikant assoziiert waren u. a. Wohnort in den neuen Bundesländern und jüngeres Alter. Entgegen geltender Empfehlung wurden ca. 75 % der Tetanus-Impfungen in Notaufnahmen bzw. Stationen als monovalente Impfung verabreicht. Schlussfolgerungen: Angesichts hoher Pertussis-Inzidenzen und niedriger Durchimpfung in Risikogruppen und der Allgemeinbevölkerung ist die Steigerung der Pertussis-Impfquoten in Deutschland dringend geboten. Impfquotensteigernde Maßnahmen sollten unbedingt die impfende Ärzteschaft miteinbeziehen. Background: Pertussis vaccination for risk-groups (e. g. healthcare workers, employees of communal facilities, or persons with close contact to infants) has been recommended in Germany since 2001. In 2009, single-dose acellular pertussis (ap) vaccination was recommended for all adults at the next tetanus-diphtheria (Td) booster. Study aims were to assess 1) pertussis vaccination coverage in adults, and 2) use of tetanus-containing combination vaccines in hospitals. Methods: For 1) we analysed data from two population-based telephone surveys conducted among adults in Germany in 2009/2010 (GEDA09: n = 21 262; GEDA10: n = 22 050). Factors associated with vaccination were identified by logistic regression analyses. For 2) a questionnaire survey of 133 hospital pharmacies serving 454 German hospitals was undertaken for the year 2007. Results: Overall, 5.9 % (95 % confidence interval [CI] 5.5–6.3 %) of GEDA10 participants reported up-to-date pertussis vaccination (ap-vaccination in past 10 years). In risk-groups, vaccination coverage was 10.7 % (95 %-CI 9.8–11.7 %). Residence in former East-Germany and younger age were independently associated with an adequate vaccination status. Contrary to prevailing recommendations, ~75 % of tetanus vaccines were administered as monovalent rather than Td- (or Tdap-)combination vaccines in hospitals. Conclusions: In light of high pertussis-incidence and low vaccination coverage in German adults, improvement of pertussis vaccine uptake is vital, e. g. through awareness campaigns targeting both physicians in private practice and hospitals.


  • Saisonale und pandemische Influenzaimpfung: Impfquoten und Einstellung niedergelassener Ärzte in Deutschland

    by M. M. Böhmer, D. Walter, J. Ehrhardt, S. Reiter, G. Krause, O. Wichmann

    Niedergelassene Ärzte spielen eine Schlüsselrolle als Multiplikatoren der saisonalen Influenzaimpfung für die von der Ständigen Impfkommission (STIKO) empfohlenen Risikogruppen wie älteren oder chronisch kranken Personen und sind auch selbst eine Zielgruppe für die Impfung. Daten aus 1 590 Telefoninterviews wurden analysiert. Studienpopulation waren niedergelassene Ärzte der (potentiell) impfenden Fachrichtungen Allgemeinmedizin, Innere Medizin, Gynäkologie und Pädiatrie. Erhoben wurden saisonale und pandemische Influenzaimpfquoten, Einstellung und Informationsbedarf hinsichtlich Schutzimpfungen allgemein sowie die Einschätzung der pandemischen Situation 2009. Von den befragten Ärzten gaben 61% an, sich regelmäßig gegen saisonale Influenza impfen zu lassen. Hauptgründe für eine nie/nur gelegentlich durchgeführte Influenzaimpfung waren, dass für sich persönlich keine Notwendigkeit für die Impfung gesehen wurde (78%) oder dass die Impfung vergessen wurde (28%). Ein großer Bedarf zur aktiven Information zu STIKO-Empfehlungen sowie bestimmten Aspekten der saisonalen Influenzaimpfung wurde geäußert. Eine deutliche Assoziation bestand zwischen der regelmäßigen eigenen Influenzaimpfung und der Verwendung von Impf-Informa­tionsmaterialien, Impfdaten-Verwaltungssystemen und der aktiven Erinnerung von Patienten an fällige Impfungen im Praxisalltag. Gegen pandemische Influenza A(H1N1) hatten sich 60% in der Saison 2009/10 impfen lassen. Vorbehalte bestanden insbesondere aufgrund von Bedenken bezüglich der Sicherheit der H1N1-Impfstoffe (angegeben von 54% der Nicht-Geimpften). Die Information der Bevölkerung und Ärzteschaft durch öffentliche Stellen während der Pandemie wurde eher kritisch bewertet. Im Vergleich zu anderen Gruppen des medizinischen Personals sind die saisonalen und pandemischen Influenzaimpfquoten bei niedergelassenen Ärzten hoch. Dem Informationsbedarf niedergelassener Ärzte könnte mit Publikationen zum Thema Impfen und der Nutzung bestehender Arzt-Informationskanäle begegnet werden. General practitioners serve as important multipliers for seasonal influenza vaccination in risk groups such as elderly or chronically ill persons, for whom vaccination is recommended in Germany by the Standing Committee on Vaccination (STIKO). Moreover, physicians are a target group for influenza vaccination themselves. Data from 1 590 telephone interviews were analysed. The study population comprised private physicians from 4 different disciplines (general and internal medicine, gynaecology, paediatrics). We assessed seasonal and pandemic vaccination coverage, attitudes and informational needs related to vaccination in general, and opinions about the pandemic situation 2009. Of the interviewed physicians, 61% stated that they have been vaccinated against seasonal influenza regularly. Main reasons for not/only occasionally having received a flu shot were: the belief that seasonal influenza vaccination is not necessary for them (78%) or having forgotten about the vaccination (28%). The interviewed physicians expressed a great demand for active information on STIKO recommendations and certain aspects of the seasonal influenza vaccination. There was a significant association between physicians’ own influenza vaccination status and the provision of vaccination information materials, utilisation of a data management system for the vaccination of patients, and active vaccination reminders in the physicians’ office. In 2009/10, almost 60% had received a pandemic influenza A(H1N1) vaccination. A major barrier to vaccine uptake was the mistrust in the safety of H1N1 vaccines (stated by 54% of non-vaccinees). Information for the public and physicians by the German public health authorities during the pandemic was rather critically appraised by the respondents. Compared to other subgroups of health-care workers, among private physicians seasonal and pandemic vaccine uptake was rather high. The physicians’ need for more information on vaccination topics can be met by intensified publishing and communication activities of STIKO and by using existing physician-information channels.


  • Open Access

    Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany

    by Merle M Böhmer, Dietmar Walter, Gerhard Falkenhorst, Stephan Müters, Gérard Krause, Ole Wichmann

    In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic influenza A(H1N1)pdm09, which was controversially discussed in the public, was recommended for the whole population. The objectives of this study were to assess vaccination coverage for seasonal (seasons 2008/09-2010/11) and pandemic influenza (season 2009/10), to identify predictors of and barriers to pandemic vaccine uptake and whether the controversial discussions on pandemic vaccination has had a negative impact on seasonal influenza vaccine uptake in Germany.


  • Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany

    by Merle M. Böhmer, Dietmar Walter, Gérard Krause, Stephan Müters, Antje Gößwald, Ole Wichmann

    The primary objective of this study was to assess determinants of vaccine uptake in adults living in Germany exemplified by one standard vaccination (tetanus) and one vaccination targeting specific risk-groups (seasonal influenza). Data from 21,262 telephone household-interviews representative of the adult population in Germany were collected in 2009 and analysed. A total 73.1% of the adult population had a sufficient tetanus vaccination status according to national recommendations (i.e. last tetanus shot ≤10 years ago). Influenza vaccination coverage in the target population (i.e. persons ≥60 years, chronically ill, healthcare workers) was 44.1%. Persons who received professional vaccination advice within the past five years were more frequently vaccinated against tetanus and influenza than persons without (p


  • Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: Results from a national health update survey

    by Merle M. Böhmer, Dietmar Walter, Stephan Müters, Gérard Krause, Ole Wichmann